companyprofile
Actions
National Medical Care Co.
- Main Market
- Health Care Equipment & Svc
Stats Overview
-
Prev. Close 188.20
-
Open 190.00
-
High 194.60
-
Low 189.80
-
No. of Trades 1,041
-
Avg. Trade size* 54
-
Volume Traded 56,225
-
Value Traded (SAR) 10,850,821.80
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Last Trade
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select a Maximum of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|---|---|---|---|
| 22/04/2024 | 22/05/2024 | 12/06/2024 | Account Transfer | 2.00 |
| 21/03/2023 | 19/06/2023 | 10/07/2023 | Account Transfer | 1.00 |
| 19/04/2022 | 17/05/2022 | 31/05/2022 | Account Transfer | 1.00 |
| 28/03/2021 | 27/05/2021 | 16/06/2021 | Account Transfer | 1.00 |
| 26/01/2020 | 15/04/2020 | 23/04/2020 | Account Transfer | 2.00 |
CompanyProfilev2Financials
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Quarterly
| Balance Sheet | 2023-12-31 | |||
|---|---|---|---|---|
| Total Assets |
2,214,365
|
- | - | - |
| Total Liabilities |
760,929
|
- | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
1,453,436
|
- | - | - |
| Total Liabilities and Shareholders Equity |
2,214,365
|
- | - | - |
| Statement of Income | 2023-12-31 | |||
| Total Revenue (Sales/Operating) |
1,081,783
|
- | - | - |
| Net Profit (Loss) before Zakat and Tax |
264,595
|
- | - | - |
| Zakat and Income Tax |
-23,667
|
- | - | - |
| Net Profit (Loss) after Zakat and Tax |
240,927
|
- | - | - |
| Total Comprehensive Income |
234,697
|
- | - | - |
| Profit (Loss) per Share |
5.37
|
- | - | - |
| Cash Flows | 2023-12-31 | |||
| Net Cash From Operating Activities |
466,737
|
- | - | - |
| Net Cash From Investing Activities |
-624,941
|
- | - | - |
| Net Cash From Financing Activities |
137,661
|
- | - | - |
| Cash and Cash Equivalents, Beginning of the Period |
329,213
|
- | - | - |
| Cash and Cash Equivalents, End of the Period |
308,670
|
- | - | - |
| All Figures in | Thousands | |||
| All Currency In | SAR | |||
| Last Update Date | 2024-02-27 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | 2024-06-30 | 2024-03-31 | 2023-09-30 | |
|---|---|---|---|---|
| Total Assets |
2,191,481
|
2,231,628
|
1,910,928
|
|
| Total Liabilities |
683,894
|
696,905
|
514,744
|
|
| Total Shareholders Equity (After Deducting the Minority Equity) |
1,507,587
|
1,534,724
|
1,396,184
|
|
| Total Liabilities and Shareholders Equity |
2,191,481
|
2,231,628
|
1,910,928
|
|
| Statement of Income | 2024-06-30 | 2024-03-31 | 2023-09-30 | |
| Total Revenue (Sales/Operating) |
296,818
|
298,561
|
275,359
|
|
| Net Profit (Loss) before Zakat and Tax |
65,115
|
74,361
|
81,657
|
|
| Zakat and Income Tax |
4,381
|
6,927
|
-8,276
|
|
| Net Profit (Loss) after Zakat and Tax |
69,496
|
81,287
|
73,381
|
|
| Total Comprehensive Income |
69,496
|
81,287
|
73,381
|
|
| Profit (Loss) per Share |
1.55
|
1.81
|
1.64
|
|
| Cash Flows | 2024-06-30 | 2024-03-31 | 2023-09-30 | |
| Net Cash From Operating Activities |
-17,241
|
46,435
|
484,263
|
|
| Net Cash From Investing Activities |
192,134
|
-168,338
|
-505,953
|
|
| Net Cash From Financing Activities |
-104,055
|
-5,673
|
-37,552
|
|
| Cash and Cash Equivalents, Beginning of the Period |
308,670
|
308,670
|
329,213
|
|
| Cash and Cash Equivalents, End of the Period |
379,509
|
181,095
|
269,972
|
|
| All Figures in | Thousands | Thousands | Thousands | |
| All Currency In | SAR | SAR | SAR | |
| Last Update Date | 2024-08-01 | 2024-05-12 | 2023-11-05 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
The activity of the company is in establishing, owning, equipping, maintaining and operating hospitals, health centers and units, providing healthcare services in all fields, any services and businesses that may cooperate in accomplishing its purposes, and owning lands and properties for the benefit of the Company.
Company History
The National Medical Care Co. was established in 2003 as a Closed Joint-Stock Company owned by the General Organization for Social Insurance (GOSI) and a group of shareholders. In 2013, it became a publicly Joint-Stock Company registered on the Saudi Stock Exchange (Tadawul). The Company currently owns several hospitals, including Riyadh Care Hospital, which has been renamed as Care Medical Alrawabi, formerly, known as the (Social Insurance Hospital) founded in 1990, which has 325 beds. The Company also owns National Care Hospital, which has been renamed as Care Medical Almalaz, founder in 1966, which has 459 beds. In addition, there is the Care Medical Alharam, which was opened in 2023. It is an emergency center located near the Holy Mosque in Mecca, providing emergency services for critical cases of pilgrims and visitors to the Holly Mosque, and Umrah performers. It has 54 beds. Lastly, there is the Care Medical AlBalad in Jeddah, specializing in long-term care, having 164 beds.
Company Bylaws
Equity Profile
- Authorized Capital (SAR) 448,500,000
- Issued Shares 44,850,000
- Paid Capital (SAR) 448,500,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :-
Investment limits
There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and instructions for the Foreign Strategic Investors Ownership in listed companies based on company's bylaw and the issued instructions by the related regulators and supervisory authorities.
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Governance & Compliance Department
Company Address:
Al Imam Ahmad Ibn hanbal St. Ar Rayyan Area P.O. Box 29393 Riyadh 11457
Contact Details:
Telephone:
00966114931881
Fax
: -
Email
: care.ir@care.med.sa
Company Website:
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.